Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for OLUMIANT
- Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study
- REVERSE-Long COVID-19 With Baricitinib Pilot Study
- Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia
- Baricitinib in Idiopathic Granulomatous Mastitis
- Baricitinib for Cutaneous Dermatomyositis
- A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis
- Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial
- Bioequivalence Study of Baricitinib From Barcimiant 4 mg Film Coated Tablets (Horus Pharma, Egypt) and Olumiant 4 mg Film Coated Tablets (Eli Lilly Nederland B.V., The Netherlands)
- Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
- EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial
- Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial)
- Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial
- mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R)
- Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
- Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation
- JAK Inhibitor Treatment in AGS
Clinical trials list
click for details